Grouping Rules
TH-Unique ยท ASEAN CSDT grouping ยท Multiple devices in one application
What Is Grouping?โ
Thai FDA allows multiple devices to be covered under a single CSDT submission where they meet defined grouping criteria. Grouping reduces the number of applications needed and can significantly reduce registration costs and timelines for product families.
The Six Grouping Types โ TH-Uniqueโ
Thailand's CSDT framework recognises six distinct grouping types:
1. Single Deviceโ
A single specific model/configuration. The baseline โ not a grouping type per se, but the reference point for all other types.
2. Familyโ
Definition: Multiple device models that share:
- The same manufacturer
- The same intended purpose
- The same design concept and principle of operation
- The same materials in patient-contacting parts
- Differences only in size, shape, colour, or minor configuration
Examples:
- A range of catheters in multiple French sizes (6Fr, 8Fr, 10Fr, 12Fr)
- Orthopaedic implants in multiple sizes (same design, varying dimensions)
- Surgical scissors in different lengths
Eligibility check: If you change the material, intended purpose, or operating principle between models, they cannot form a Family โ they require separate applications.
3. Systemโ
Definition: Multiple devices that are:
- Designed and intended to be used together as an integrated functional unit
- Each component performs a distinct function that contributes to the overall system purpose
- May include both Class 1 and higher-class devices (system is classified at the highest class of its components)
Examples:
- Infusion system: pump + infusion set + pressure monitoring
- Patient monitoring system: monitor + ECG leads + SpO2 probe + NIBP cuff
- Surgical robot: robotic unit + control station + surgical instruments
4. Setโ
Definition: Multiple devices that are:
- Packaged together for a specific clinical procedure
- Intended to be used together (or separately) for that procedure
- Not necessarily integrated โ may be individual devices in a procedure pack
Examples:
- Wound care procedure pack (dressings, forceps, gloves, gauze)
- Central line insertion kit
- Biopsy procedure set
5. IVD Test Kitโ
Definition: An IVD product comprising:
- A primary test reagent or kit
- Ancillary reagents, standards, controls, calibrators
- All components intended by the manufacturer to be used together
Examples:
- ELISA kit (plate, conjugate, substrate, stop solution, controls)
- PCR diagnostic kit (reagents, positive control, negative control, primers)
6. IVD Cluster โ TH-Uniqueโ
Definition: Multiple IVD test kits or products from the same manufacturer that:
- Detect/measure the same analyte or pathogen
- Use the same basic technological platform
- Are intended for different specimen types or user settings
Examples:
- Serum-based ELISA + whole blood rapid test โ both testing for the same hepatitis B antigen
- Professional-use PCR kit + point-of-care rapid test โ same target analyte, different platforms for different settings
Grouping Eligibility Requirements โ Common to All Typesโ
Regardless of grouping type, all devices in a group must:
| Requirement | Detail |
|---|---|
| Same manufacturer | All devices have the same legal manufacturer |
| Same intended purpose | All serve the same primary clinical function |
| Same device name | Common trade name for the group (with model distinguishers) |
| Same classification | Or if mixed, submit at the highest class |
How to Apply Groupingโ
- Select the appropriate grouping type
- List all models/variants to be included with their full model identifiers
- Provide a table comparing specifications across all variants (showing shared features and allowed differences)
- Prepare a single CSDT covering all models in the group
- Include separate labelling/IFU for each variant where labelling differs
Even in a grouped application, each device variant must be adequately described and its characteristics documented. The CSDT must cover the full range of variants, not just one representative model.
Changing a Grouped Applicationโ
If a new variant is added to an existing approved group, submit a variation notification to Thai FDA. The new variant must meet the same grouping eligibility criteria as the original group.